Hemophilia A With Inhibitors Completed Phase 4 Trials for Ascorbic acid (DB00126)

Also known as: Hemophilia A With Inhibitor / Haemophilia A With Inhibitors

IndicationStatusPhase
DBCOND0032571 (Hemophilia A With Inhibitors)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03093480A Study to Evaluate Efficacy of rFVIIIFc for Immune Tolerance Induction (ITI) in Severe Hemophilia A Participants With Inhibitors Undergoing the First ITI Treatment (verITI-8 Study)Treatment